HROW Q3 2019 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$13M+18.8% YoY

Gross Profit

$9M68.2% margin

Operating Income

-$4M-34.5% margin

Net Income

-$11M-89.9% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

-5.6%

Cash Flow

Operating Cash Flow

-$70,000

Free Cash Flow

-$153,000

Stock-Based Comp.

$403,000

Balance Sheet

Total Assets

$55M

Total Liabilities

$31M

Stockholders' Equity

$24M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$13M	$11M	+18.8%
Gross Profit	$9M	$7M	+32.8%
Operating Income	-$4M	-$649,000	-577.7%
Net Income	-$11M	-$3M	-356.2%

Revenue Segments

License Revenues

$7,000100%